PRTN3 and arthritic joint disease: In this regard, our group has described in patients of an early arthritis cohort with a median symptom duration about 5 months that the ACPA positive subjects showed a significantly lower systemic bone mass at hip and lumbar spine, but not at periarticular level in metacarpophalangeal joints.